Calamos Wealth Management LLC increased its position in shares of Danaher Co. (NYSE:DHR – Free Report) by 1,646.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 60,925 shares of the conglomerate’s stock after buying an additional 57,436 shares during the period. Danaher makes up 0.7% of Calamos Wealth Management LLC’s holdings, making the stock its 29th biggest holding. Calamos Wealth Management LLC’s holdings in Danaher were worth $13,985,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in the business. Fort Pitt Capital Group LLC raised its position in shares of Danaher by 3.2% in the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock valued at $66,194,000 after purchasing an additional 7,421 shares during the period. Good Life Advisors LLC purchased a new stake in Danaher during the third quarter valued at about $217,000. ORG Partners LLC lifted its stake in Danaher by 1,212.8% during the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock worth $636,000 after purchasing an additional 2,559 shares during the last quarter. Harvest Portfolios Group Inc. increased its position in shares of Danaher by 1.2% during the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock valued at $56,233,000 after purchasing an additional 2,465 shares during the last quarter. Finally, Stifel Financial Corp grew its holdings in shares of Danaher by 1.3% during the 3rd quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock valued at $235,583,000 after purchasing an additional 11,216 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on the company. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a research note on Friday, December 13th. Guggenheim assumed coverage on shares of Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 price target for the company. Raymond James reiterated a “market perform” rating on shares of Danaher in a research report on Monday. Royal Bank of Canada restated an “outperform” rating and issued a $277.00 target price (down from $299.00) on shares of Danaher in a report on Thursday, January 30th. Finally, KeyCorp boosted their target price on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average target price of $278.00.
Danaher Price Performance
Shares of NYSE DHR opened at $214.09 on Tuesday. Danaher Co. has a twelve month low of $214.03 and a twelve month high of $281.70. The stock’s 50 day moving average price is $235.40 and its 200-day moving average price is $253.09. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $154.64 billion, a PE ratio of 40.55, a PEG ratio of 2.80 and a beta of 0.83.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the business posted $2.09 earnings per share. On average, equities analysts anticipate that Danaher Co. will post 7.77 EPS for the current year.
Danaher Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.50%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s dividend payout ratio (DPR) is currently 20.45%.
Insiders Place Their Bets
In other news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 10.90% of the company’s stock.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- The 3 Best Blue-Chip Stocks to Buy Now
- T-Mobile: The Best Wireless Carrier Stock to Own Right Now?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Boeing: Charting a Course for Recovery and Redemption
- Industrial Products Stocks Investing
- Top 3 High-Momentum Companies Analysts Are Still Bullish On
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.